Evidence map›Paper›PMID 38247448›Full record

ArticleJournal of the National Cancer Institute2024

Cancer mortality in chrysotile miners and millers, Russian Federation: main results (Asbest Chrysotile Cohort-Study).

Joachim Schüz, Evgeny Kovalevskiy, Ann Olsson, Monika Moissonnier, Evgenia Ostroumova, Gilles Ferro, Eleonora Feletto, Sara J Schonfeld, Graham Byrnes, Iraklii Tskhomariia and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 5 countries.

Joachim SchüzInternational Agency for Research on Cancer-World Health Organization, Lyon, France.ORCID 0000-0001-9687-2134
Evgeny KovalevskiyFederal State Budgetary Scientific Institution, Izmerov Research Institute of Occupational Health, Moscow, Russian Federation.
Ann OlssonInternational Agency for Research on Cancer-World Health Organization, Lyon, France.ORCID 0000-0001-6498-2259
Monika MoissonnierInternational Agency for Research on Cancer-World Health Organization, Lyon, France.
Evgenia OstroumovaInternational Agency for Research on Cancer-World Health Organization, Lyon, France.
Gilles FerroInternational Agency for Research on Cancer-World Health Organization, Lyon, France.
Eleonora FelettoInternational Agency for Research on Cancer-World Health Organization, Lyon, France.ORCID 0000-0001-6192-4694
Sara J SchonfeldInternational Agency for Research on Cancer-World Health Organization, Lyon, France.
Graham ByrnesInternational Agency for Research on Cancer-World Health Organization, Lyon, France.
Iraklii TskhomariiaFederal State Budgetary Scientific Institution, Izmerov Research Institute of Occupational Health, Moscow, Russian Federation.
Kurt StraifInternational Agency for Research on Cancer-World Health Organization, Lyon, France.ORCID 0000-0003-1402-2406
Tatiana MorozovaI.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation.
Hans KromhoutInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.ORCID 0000-0002-4233-1890
Igor BukhtiyarovFederal State Budgetary Scientific Institution, Izmerov Research Institute of Occupational Health, Moscow, Russian Federation.
Centre international de recherche sur le cancer · FRSechenov University · RUNational Institutes of Health · USThe Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" · RUThe University of Sydney · AUUtrecht University · NL

Funding

Federal State Budgetary Scientific InstitutionInternational Agency for Research on CancerIntramural NIH HHSIzmerov Research Institute of Occupational HealthMinistry of Health of the Russian FederationNational System of Chemical and Biological Safety of the Russian Federation 2009-2014NCI NIH HHSNIH HHSWorld Health Organization 001World Health Organization 2015-2023
6 · The paper itself

Abstract

backgroundWe investigated mortality in workers of the world's largest chrysotile mine and enrichment factories located in the town of Asbest, Russian Federation.

methodsThis historical cohort study included all workers employed for at least 1 year between 1975 and 2010 and follow-up until the end of 2015. Cumulative exposure to dust was estimated based on workers' complete occupational history linked to dust measurements systematically collected from the 1950s. Exposure to chrysotile fibers was estimated using dust-to-fiber conversion factors. Relative risks (RRs) and 95% confidence intervals (CIs) were estimated as mortality rate ratios in Poisson regression models.

resultsA total of 30 445 (32% women) workers accumulated 721 312 person-years at risk and 11 110 (36%) died. Of the workers, 54% had more than 30 years since their first exposure. We found an exposure-response between cumulative dust and lung cancer mortality in men. No clear association with dust exposure but a modest increase in the highest category of fiber exposure was seen for lung cancer in women. Mesothelioma mortality was increased (RR = 7.64, 95% CI = 1.18 to 49.5, to at least 80 fibers per cm3 years and RR = 4.56, 95% CI = 0.94 to 22.1, to at least 150 mg/m3 years [dust]), based on 13 deaths. For colorectal and stomach cancer, there were inconsistent associations. No associations were seen for laryngeal or ovarian cancer.

conclusionIn this large-scale epidemiological study in the world's largest active asbestos mine, we confirmed an increased risk of mesothelioma with high fiber exposure and an increasing mortality for lung cancer in men with increasing dust exposure. Less clear-cut increased lung cancer mortality was seen in the women. Continued mortality follow-up is warranted.

Indexed as

Asbestos, SerpentineLung NeoplasmsOccupational DiseasesOccupational ExposureAdultAgedCohort StudiesDustFemaleHumansMaleMiddle AgedMinersMiningRussiaAsbestos, SerpentineDust

Identifiers

PMID38247448
PMCPMC11160488
OpenAlexW4391109356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.